Medication info
Koroza Plus Tablets

Koroza Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Yellow oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201207577 · Approved 2012.10.31 · Insurance code 698502230

Summary

Main use
Treatment of hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start treatment with this medicine only when the expected effect has not been achieved with monotherapy. 1. Substitution therapy: A regimen of dose-adjusted losartan potassium and hydrochlorothiazide administered concomitantly as separate products may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which reduces the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. The clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg should then be monitored continuously; if blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or higher. Administration is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Administration is not recommended in patients with hepatic impairment requiring dose adjustment, since the initial dose of losartan potassium for such patients, 25 mg, cannot be administered using this product.
Child dose
Children (under 18 years): Since there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of hypertension not controlled with monotherapy

  • Hypertension
View approved original text

This medication is used additionally in patients with hypertension for whom blood pressure control is insufficient with monotherapy, helping to effectively lower blood pressure.

How to take

Adult dose

○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start treatment with this medicine only when the expected effect has not been achieved with monotherapy. 1. Substitution therapy: A regimen of dose-adjusted losartan potassium and hydrochlorothiazide administered concomitantly as separate products may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which reduces the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. The clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg should then be monitored continuously; if blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or higher. Administration is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Administration is not recommended in patients with hepatic impairment requiring dose adjustment, since the initial dose of losartan potassium for such patients, 25 mg, cannot be administered using this product.

Child dose

Children (under 18 years): Since there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be immediately discontinued upon confirmation of pregnancy. This medication should not be administered to patients with certain allergies, severely impaired renal function, severe liver disorder, pregnant women or those who could become pregnant, and patients with certain genetic metabolic disorders. Caution is required when using this medication in patients with low blood pressure, decreased kidney function, liver disease, diabetes, or gout. Particularly in the elderly, adverse reactions may occur more frequently, warranting careful monitoring. This medication lowers blood pressure, which may cause dizziness or drowsiness; caution should be exercised when driving or operating machinery. During treatment with this medication, electrolyte status and kidney function should be monitored regularly through blood tests, and care should be taken to prevent potassium levels from becoming too high or too low. This medication may interact with other drugs, so it is essential to consult with a physician or pharmacist, especially if potassium supplements, potassium-sparing diuretics, certain diuretics, antihypertensive medications, or non-steroidal anti-inflammatory drugs are being used. The Hydrochlorothiazide component may increase sensitivity to sunlight, raising the risk of skin cancer; therefore, it is important to avoid sun exposure and take protective measures. If symptoms such as sudden vision changes, eye pain, severe rash, or difficulty breathing occur during treatment with this medication, immediate medical attention should be sought. Women who are pregnant or planning to become pregnant should consult with a physician before taking this medication, and breastfeeding women should also be cautious as this medication may pass into breast milk. Safety and effectiveness have not been established for children and adolescents, therefore this medication should not be administered to them. In cases of overdose, symptoms such as hypotension and heart rhythm disturbances may occur; if these symptoms appear, immediate consultation with healthcare professionals is necessary, and this medication cannot be removed by hemodialysis, requiring specialized treatment. This medication should be kept out of the reach of children, and stored in its original container to prevent misuse or degradation of quality.

Side effects

  • Craniosynostosis
  • Anuria
  • Hypotension
  • Renal Failure
  • Death
  • Abdominal Pain
  • Edema
  • Palpitations
  • Back Pain
  • Dizziness
Show 131 more
  • Cough
  • Sinusitis
  • Upper Respiratory Infection
  • Rash
  • Angioedema
  • Skin Peeling
  • Hemolysis
  • Chest Pain
  • Facial Edema
  • Fever
  • Orthostatic Hypotension
  • Syncope
  • Angina
  • Arrhythmia
  • Cerebrovascular Accident
  • Myocardial Infarction
  • Secondary Atrioventricular Block
  • Loss of Appetite
  • Constipation
  • Toothache
  • Dry Mouth
  • Dyspepsia
  • Flatulence
  • Gastritis
  • Vomiting
  • Lethargy
  • Anemia
  • Gout
  • Arm Pain
  • Arthralgia
  • Arthritis
  • Fibromyalgia
  • Hip Pain
  • Joint Swelling
  • Knee Pain
  • Limb Pain
  • Muscle Cramps
  • Muscle Weakness
  • Musculoskeletal Pain
  • Myalgia
  • Shoulder Pain
  • Muscle Rigidity
  • Anxiety
  • Anxiety Disorder
  • Ataxia
  • Confusion
  • Depression
  • Nightmares
  • Sensory Loss
  • Insomnia
  • Decreased Libido
  • Memory Impairment
  • Migraine
  • Neuroirritability
  • Panic Disorder
  • Sensory Disturbance
  • Peripheral Neuropathy
  • Sleep Disorder
  • Drowsiness
  • Tremor
  • Dyspnea
  • Epistaxis
  • Nasal Congestion
  • Pharyngeal Discomfort
  • Respiratory Congestion
  • Rhinitis
  • Venous Sinus Disorder
  • Chest Discomfort
  • Alopecia
  • Dermatitis
  • Dry Skin
  • Petechiae
  • Erythema
  • Flushing
  • Photosensitivity Reaction
  • Pruritus
  • Sweating
  • Urticaria
  • Blurred Vision
  • Ocular Pain
  • Burning Sensation
  • Conjunctivitis
  • Vision Impairment
  • Taste Disturbance
  • Tinnitus
  • Erectile Dysfunction
  • Nocturia
  • Frequent Urination
  • Urinary Tract Infection
  • Weakness
  • Pancreatitis
  • Jaundice
  • Salivary Gland Inflammation
  • Spasm
  • Gastrointestinal Irritation
  • Aplastic Anemia
  • Agranulocytosis
  • Leukopenia
  • Hemolytic Anemia
  • Thrombocytopenia
  • Purpura
  • Necrotizing Vasculitis
  • Pneumonia
  • Pulmonary Edema
  • Acute Respiratory Distress Syndrome
  • Hyperglycemia
  • Diabetes
  • Muscle Spasm
  • Restlessness
  • Renal Failure
  • Renal Dysfunction
  • Interstitial Nephritis
  • Stevens-Johnson Syndrome
  • Erythema Multiforme
  • Toxic Epidermal Necrolysis
  • Temporary Blurred Vision
  • Yellow Vision
  • Acute Myopia
  • Acute Closed-Angle Glaucoma
  • Choroidal Exudate
  • Hypotension
  • Tachycardia
  • Vasculitis
  • Anaphylactic Reaction
  • Hepatitis
  • Intestinal Vascular Edema
  • Dry Cough
  • Erythema
  • Hyperkalemia
  • Hyponatremia
  • Rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a tightly closed container that blocks light. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Yellow oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.